Saving your money for next purchases
Pertuzumab 帕妥珠单抗
Pertuzumab (Pertuzumab, also known as 2C4, trade name Perjeta) is a monoclonal antibody. It is the first monoclonal antibody called a “HER dimerization inhibitor.” By binding to HER2, it blocks the heterodimerization of HER2 with other HER receptors, thereby slowing down tumor growth [1]. Pertuzumab was approved by the US FDA on June 8, 2012, for the treatment of HER2-positive metastatic breast cancer [2].
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
